Production of anti-double-stranded DNA antibodies in activated lymphocyte derived DNA induced lupus model was dependent on CD4 + T cells

Lupus

Volumn 21, Issue 5, 2012, Pages 508-516

  Wen, Z ^a   Xu, L ^a   Xu, W ^a,b   Xiong, S ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

activated lymphocyte derived DNA; anti dsDNA antibody; CD4 + T cell; SLE

Indexed keywords

ACTIVATED LYMPHOCYTE DERIVED DNA; DNA; DOUBLE STRANDED DNA ANTIBODY; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HELPER CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL DEPLETION;

ANIMALS; ANTIBODIES; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DNA; FEMALE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, NUDE;

EID: 84859358187     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311434940     Document Type: Article

References (31)

1. Swaak AJ, Groenwold J, Aarden LA, Statius van Eps LW, Feltkamp EW. Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis. 1982 ; 41: 388-395 (Pubitemid 12038906)
2. Von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum. 1995 ; 24: 323-358
3. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008 ; 358: 929-939 (Pubitemid 351397092)
4. Sanz I, Lee FE, Medscape . B cells as therapeutic targets in SLE. Nat Rev Rheumatol. 2010 ; 6: 326-337
5. Perl A, Fernandez D, Telarico T, Phillips PE. Endogenous retroviral pathogenesis in lupus. Curr Opin Rheumatol. 2010 ; 22: 483-492
6. Qiao B, Wu J, Chu YW, et al. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA. Rheumatology (Oxford). 2005 ; 44: 1108-1114 (Pubitemid 41236016)
7. Wen ZK, Xu W, Xu L, et al. DNA hypomethylation is crucial for ALD-DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford). 2007 ; 46: 1796-1803 (Pubitemid 350168294)
8. Zhang W, Xu W, Xiong S. Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. J Immunol. 2010 ; 184: 6465-6478
9. Zhang W, Wu J, Qiao B, Xu W, Xiong S. Amelioration of lupus nephritis by serum amyloid p component gene therapy with distinct mechanisms varied from different stage of the disease. PLoS One. 2011 ; 6: e22659 - e22659
10. Zhang W, Xu W, Xiong S. Macrophage differentiation and polarization via phosphatidylinositol 3-kinase/Akt-ERK signaling pathway conferred by serum amyloid P component. J Immunol. 2011 ; 187: 1764-1777
11. 3 antibody is most effective when preinjected in the marrow recipient. Blood. 1992 ; 80: 2661-2667
12. 3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis. J Immunol. 2000 ; 165: 4231-4238
13. Pisetsky DS, Grammer AC, Ning TC, Lipsky PE. Are autoantibodies the targets of B-cell-directed therapy?. Nat Rev Rheumatol. 2011 ; 7: 551-556
14. Atamaniuk J, Hsiao YY, Mustak M, et al. Analysing cell-free plasma DNA and SLE disease activity. Eur J Clin Invest. 2011 ; 41: 579-583
15. Okabe Y, Kawane K, Akira S, Taniguchi T, Nagata S. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from ALD-DNA degradation. J Exp Med. 2005 ; 202: 1333-1339 (Pubitemid 41668736)
16. Nagata S. DNA degradation in development and programmed cell death. Annu Rev Immunol. 2005 ; 23: 853-875 (Pubitemid 40563187)
17. Pisetsky DS. The immunologic properties of DNA. J Immunol. 1996 ; 156: 421-423 (Pubitemid 26028897)
18. Coscoy L, Raulet DH. DNA mismanagement leads to immune system oversight. Cell. 2007 ; 131: 836-838 (Pubitemid 350138093)
19. Balada E, Ordi-Ros J, Vilardell-Tarrés M. DNA methylation and systemic lupus erythematosus. Ann N Y Acad Sci. 2007 ; 1108: 127-136 (Pubitemid 47528726)
20. Patel DR, Richardson BC. Epigenetic mechanisms in lupus. Curr Opin Rheumatol. 2010 ; 22: 478-482
21. Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun. 2010 ; 34: J207 - J219
22. Kawane K, Fukuyama H, Yoshida H, et al. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat Immunol. 2003 ; 4: 138-144 (Pubitemid 36193015)
23. Agrawal A, Tay J, Yang GE, Agrawal S, Gupta S. Age-associated epigenetic modifications in human DNA increase its immunogenicity. Aging (Albany NY). 2010 ; 2: 93-100
24. Javierre BM, Richardson B. A new epigenetic challenge: systemic lupus erythematosus. Adv Exp Med Biol. 2011 ; 711: 117-136
25. Pan Y, Sawalha AH. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl Res. 2009 ; 153: 4-10
26. Zhu X, Liang J, Li F, Yang Y, Xiang L, Xu J. Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus. Int J Dermatol. 2011 ; 50: 697-704
27. Renaudineau Y, Youinou P. Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med. 2011 ; 60: 10-16
28. Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun. 2010 ; 34: J207 - J219
29. Pisetsky DS. The role of innate immunity in the induction of autoimmunity. Autoimmun Rev. 2008 ; 8: 69-72
30. Yung S, Chan TM. Anti-DNA antibodies in the pathogenesis of lupus nephritis-the emerging mechanisms. Autoimmun Rev. 2008 ; 7: 317-321
31. Urbonaviciute V, Fürnrohr BG, Meister S, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med. 2008 ; 205: 3007-3018